Charlotte’s Web Q4 Earnings Call Highlights

0
112
Charlotte’s Web logo

Charlotte’s Web (TSE:CWEB) used its fourth-quarter 2025 earnings call to highlight what CEO Bill Morachnick called a “not business as usual” period for the company, pointing to a balance sheet restructuring with British American Tobacco (BAT), a new Medicare-related distribution pathway for hemp-derived CBD products, and progress in a pharmaceutical-adjacent clinical program through DeFloria.

Morachnick said the company entered into a financial transaction with BAT tied to BAT’s existing convertible loan note. The deal has two components: the conversion of BAT’s outstanding $55 million convertible debenture plus roughly $10 million in accrued interest into Charlotte’s Web common shares at a conversion price of CAD 0.94 per share, and a new $10 million equity investment through a private placement.

→ The Often-Missed Corner of…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here